JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3776
Smith & Wesson
SWBI
$656M
| $1.17M | ﹤0.01% |
88,881
+11,106
| +14% | +$161K |
2015 Q4
26 quarters
|
|
|
BASE
3777
DELISTED
Couchbase
BASE
| $1.17M | ﹤0.01% |
70,948
+24,275
| +52% | +$383K |
2021 Q3
3 quarters
|
|
3778
CALL
Exelixis
EXEL
$14.5B
| $1.17M | ﹤0.01% |
+56,000
| New | +$1.15M |
2022 Q2
0 quarters
|
|
3779
Mercantile Bank Corp
MBWM
$1.03B
| $1.16M | ﹤0.01% |
36,421
+12,957
| +55% | +$419K |
2016 Q2
24 quarters
|
|
3780
iShares 0-3 Month Treasury Bond ETF
SGOV
$111B
| $1.16M | ﹤0.01% |
+11,621
| New | +$1.16M |
2022 Q2
0 quarters
|
|
|
EGLE
3781
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.16M | ﹤0.01% |
22,403
+15,218
| +212% | +$974K |
2017 Q4
18 quarters
|
|
3782
Invivyd
IVVD
$242M
| $1.16M | ﹤0.01% |
353,053
-13,339
| -4% | -$41.8K |
2021 Q3
3 quarters
|
|
|
TRTL
3783
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $1.16M | ﹤0.01% |
119,849
-80,151
| -40% | -$777K |
2021 Q4
2 quarters
|
|
3784
TaskUs
TASK
$739M
| $1.15M | ﹤0.01% |
68,374
+33,280
| +95% | +$848K |
2021 Q4
2 quarters
|
|
3785
Primis Financial Corp
FRST
$387M
| $1.15M | ﹤0.01% |
84,598
+65,278
| +338% | +$876K |
2016 Q1
25 quarters
|
|
3786
CALL
Newmont
NEM
$122B
| $1.15M | ﹤0.01% |
19,300
-132,500
| -87% | -$9.37M |
2021 Q4
2 quarters
|
|
3787
Vanda Pharmaceuticals
VNDA
$280M
| $1.15M | ﹤0.01% |
105,112
-258,656
| -71% | -$2.68M |
2015 Q4
26 quarters
|
|
3788
Navios Maritime Partners
NMM
$2.68B
| $1.14M | ﹤0.01% |
49,760
+220
| +0.4% | +$6.42K |
2021 Q1
5 quarters
|
|
3789
Olema Pharmaceuticals
OLMA
$720M
| $1.14M | ﹤0.01% |
280,981
+252,181
| +876% | +$800K |
2020 Q4
6 quarters
|
|
3790
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.27B
| $1.14M | ﹤0.01% |
49,410
+7,558
| +18% | +$179K |
2021 Q1
5 quarters
|
|
|
CHS
3791
DELISTED
Chicos FAS, Inc.
CHS
| $1.14M | ﹤0.01% |
230,187
-40,047
| -15% | -$202K |
2013 Q2
36 quarters
|
|
|
DOZR
3792
DELISTED
Direxion Daily US Infrastructure Bull 2X Shares
DOZR
| $1.14M | ﹤0.01% |
50,000
| – | – |
2021 Q3
3 quarters
|
|
3793
Celldex Therapeutics
CLDX
$2.49B
| $1.14M | ﹤0.01% |
42,346
+7,458
| +21% | +$217K |
2017 Q4
18 quarters
|
|
3794
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$35.8B
| $1.14M | ﹤0.01% |
30,987
-2,709
| -8% | -$107K |
2019 Q4
10 quarters
|
|
3795
Noble Corp
NE
$6.5B
| $1.14M | ﹤0.01% |
44,914
+27,749
| +162% | +$913K |
2021 Q3
3 quarters
|
|
|
ZENV
3796
DELISTED
Zenvia
ZENV
| $1.14M | ﹤0.01% |
540,022
-226,871
| -30% | -$1.08M |
2021 Q3
3 quarters
|
|
3797
Astec Industries
ASTE
$967M
| $1.14M | ﹤0.01% |
27,883
-1,139
| -4% | -$48.5K |
2016 Q4
22 quarters
|
|
3798
GoPro
GPRO
$279M
| $1.14M | ﹤0.01% |
205,209
-288,924
| -58% | -$2.11M |
2014 Q3
31 quarters
|
|
|
BZUN
3799
Baozun
BZUN
$183M
| $1.14M | ﹤0.01% |
103,725
-55,809
| -35% | -$490K |
2019 Q4
10 quarters
|
|
3800
PUT
Integer Holdings
ITGR
$4.3B
| $1.13M | ﹤0.01% |
+16,000
| New | +$1.22M |
2022 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.